Research programme: gastrointestinal disorders therapy - The BioBalance Corporation
Alternative Names: Gastrointestinal disorders therapy research programme - The BioBalance CorporationLatest Information Update: 31 Jul 2006
At a glance
- Originator The BioBalance Corporation
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 31 Jul 2006 No development reported - Preclinical for Gastrointestinal disorders in USA (unspecified route)
- 31 Aug 2003 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)